Today, we reported our 2024 Second Quarter Financial Results, which underscore continued progress on commercial execution, driving our Growth Portfolio and advancing our pipeline. “Our second quarter results reflect progress against our strategy to position BMS for long-term, sustainable growth,” said Chris Boerner, Ph.D., board chair and CEO, Bristol Myers Squibb. “As we move into the second half of the year, we remain focused on prioritizing opportunities with the greatest growth potential and impact for patients, including the anticipated U.S. launch of KarXT. We’re also driving operational excellence throughout the company, becoming more agile and strengthening execution.” Read more, including important cautionary statements about forward-looking information, here: https://bit.ly/4cXmyuH
About us
At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients. Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do. Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html
- Website
-
http://www.bms.com
External link for Bristol Myers Squibb
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- Lawrence Township, NJ
- Type
- Public Company
- Specialties
- biotechnology, innovation, great place to work, pharmaceuticals, research and development, and healthcare
Locations
Employees at Bristol Myers Squibb
Updates
-
Bristol Myers Squibb reposted this
As we begin wrapping Disability Pride Month, I’d like to share some of what Bristol Myers Squibb is doing to help support the disability community and drive change. Because, more than a health outcome, disabilities are part of the human experience for so many. #disabilityawareness #BMSemployee #healthequity
-
We’ve achieved major milestones in environmental sustainability, reducing our impacts on the planet and demonstrating progress against our ESG goals: ✔️ Validation by the Science Based Targets initiative (SBTi) for our near-term and net-zero environment targets ✔️ Honored with the 2024 ENERGY STAR Partner of the Year: Sustained Excellence award ✔️ Earned USGBC’s LEED Platinum certification for our state-of-the-art research facility in Cambridge, Massachusetts ✔️ Named to Dow Jones Sustainability Index North America Learn more about our progress: bit.ly/3SiXCFx #Sustainability #EnvironmentalStewardship #SBTi
-
We’re honored to be recognized as one of the 2024 Best Places to Work for Disability Inclusion, earning 100 on the Disability:IN Disability Equality Index® (DEI). This #DisabilityPrideMonth, learn how our Disability Advancement Workplace Network (DAWN) People Business and Resource Group fosters our culture of inclusion where our colleagues with disabilities are valued and respected: https://bit.ly/4d5yY37 #DEI24
-
-
Bristol Myers Squibb reposted this
As PRIDE month comes to a close, I’d like to reflect on the incredible sense of community and support I witnessed throughout June. Our journey began with a powerful flag-raising ceremony that set the tone for a month of unity and inclusivity. We marched with joy and solidarity in the PRIDE parade, showcasing our unwavering support for LGBTQ+ rights. Our patient panel provided invaluable insights and fostered deep, meaningful conversations about the experiences and challenges faced by LGBTQ+ individuals. And finally, our delightful Drag Queen Charity Bingo event brought us all together for an afternoon of fun, laughter, and fundraising for vital LGBTQ+ charities. None of this would be possible without the hard work of our Bristol Myers Squibb PRIDE Alliance team, who turns our values into real-life actions that make an impact. Thank you to everyone who participated, supported, and celebrated with us this month. Together, we continue to build a more inclusive and compassionate community, both within our organization and beyond. #BMSemployee
-
-
We have been recognized by S&P Global’s Dow Jones Sustainability Index North America as a corporate sustainability industry leader. This accomplishment reflects our commitment to continuously improving our environmental, social and governance practices to creating a sustainable around the world. Learn more about our commitment to operating responsibly: https://bit.ly/3W1c5Ip #DJSI #sustainability #ESG
-
-
Sixty of our colleagues in Australia, China, Japan, Korea, Taiwan and the United States begin their #C2C4C Japan fundraising this month, culminating in an epic bike ride this October. Learn about their journey as they raise funds for CancerNet Japan to advance cancer research for patients. See more: https://bit.ly/4cjOw3o
-
We’ve advanced LGBTQIA+ inclusion in over a dozen U.S. clinical trials since last year by implementing orientation, gender identity, and intersex status (SOGIIS) data. This #PrideMonth, learn about our efforts to do more across the industry to expand clinical trial diversity while respecting patients’ privacy: https://bit.ly/4cjtkuf
-
-
Bristol Myers Squibb reposted this
The Economist Impact has just released a report commissioned by Bristol Myers Squibb (BMS) on how to address the undertreatment and unmet needs of #psoriasis patients. If you missed the discussion with Prof Jo Lambert, Frida Dunger, Executive Director of IFPA, and Leah Howard, J.D., President and CEO of National Psoriasis Foundation access the online recording from #IFPAConference2024 and read the report here. https://lnkd.in/d4RJsvsB
-
Affiliated pages
Similar pages
Browse jobs
Stock
BMY
NYSE
20 minutes delay
$50.45
5.18 (11.443%)
- Open
- 48.27
- Low
- 47.73
- High
- 50.61
Data from Refinitiv
See more info on